Use of epa and dha in secondary prevention

Details Use of epa and dha in secondary prevention Use of epa and dha in secondary prevention

A - Human Necessities

61

K

A61K 31/202 (2006.01) A61K 9/48 (2006.01) A61P 7/00 (2006.01)

Patent

CA 2485116

The invention is directed to the use of the n-3 PUFA EPA and/or DHA in the preparation of an oral medicament for preventing cerebral damage in patients having symptoms of atherosclerosis of arteries supplying the brain.

Cette invention a trait à l'utilisation d'acides gras poly-insaturés n-3 (PUFA) EPA et/ou de DHA aux fins de la préparation d'un médicament ,administrable par voie orale, destiné à prévenir des dommages cérébraux chez des patients présentant des symptômes d'athérosclérose des artères irriguant le cerveau.

Affiliated with

Also associated with

Rating

Use of epa and dha in secondary prevention does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of epa and dha in secondary prevention, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of epa and dha in secondary prevention will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1365408